Latest posts
-
AURI Double Dividend, New website ecosystem, listings and more
DALLAS, TX, October 2, 2023 – Auri Inc. (OTC PINK: AURI) (“AURI”) (the “Company”) is proud to announce an October 2, 2023 ex-dividend date on the AURI Token as well as a second dividend to holders of AURI Tokens. Over the summer of 2023 the company announced an Ex dividend date of October 2, 2023, to give
-
AURI signs Riddick Bowe, The Champ as the new Black Dragon BDGR
DALLAS, TX, September 29, 2023 – Auri Inc. (OTC PINK: AURI) (“AURI”) (the “Company”) is proud to announce today the signing of Heavyweight World Champion, Riddick Bowe as the New Black Dragon Crypto Currency namesake. Auri Inc., recently acquired a host of private and public companies for its portfolio. The goal is to build Auri Inc as
-
BioStem Technologies: CMS Decision a “Win For Patients”
POMPANO BEACH, FLORIDA, September 29, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today hails a decision by the Centers for Medicare & Medicaid Services (CMS) as being in the best interests of patients. Three Medicare
-
SKYX to Significantly Expand Market Penetration with QUOIZEL Collaboration
“In my 32 years in the lighting business. It is by far the most disruptive technology I have seen and will transform the lighting industry from the old existing hardwire installation method to a safe plug-and-play installation method.” Rick Seidman, Chief Executive Officer of QUOIZEL September 28, 2023 Disruptive platform technology company, SKYX (Nasdaq: SKYX) will
-
Neon Bloom Signs Letter of Intent to Acquire Advanced Executive Sales, LLC
Acquisition Expected to Initially Increase Annual Revenues by $20 Million this Year COLUMBIA, MD, September 28, 2023 – Neon Bloom, Inc. (OTC PINK: NBCO), announced today that it has signed a Letter of Intent to acquire Advanced Executive Sales, LLC (AES), a leading financial services company specializing in generating transactional revenue for many types of
-
2024 World Battery & Energy Storage Industry Expo (WBE) – 2024 World Hydrogen Energy Industry Expo (WHE)
2024 World Battery & Energy Storage Industry Expo (WBE) 2024 World Hydrogen Energy Industry Expo (WHE) Date: August 8th-10th, 2024 Venue: 1st and 2nd Floor, Area A, China Import and Export Fair Complex Address: No.380, Yuejiang Zhong Road, Guangzhou, China Review of WBE 2023 Organized by Guangzhou Honest Exhibition Co., Ltd, the 8th World Battery
-
AURI signs The Champ, and launches new products line
DALLAS, TX, September 27, 2023 – Auri Inc. (OTC PINK: AURI) (“AURI”) (the “Company”) is proud to announce today the signing of Heavyweight World Champion, Riddick Bowe. Auri Inc. is launching “The Champ” line of consumable products featuring CBD and THC Delta 9 infused Gummies, Energy Drinks, Vitamin Water and a host of other Nutraceutical products. These
-
StemSation International Announces Acquisition Plans
StemSation International is providing updates on corporate planning and direction for potential new acquisitions in the green energy space Plantation, Florida, September 27, 2023 – StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing strategic acquisition planning for the upcoming
-
BioStem Technologies Takes on Diabetic Foot Ulcers with Innovative Wound Care Product
“We have already demonstrated scientifically that our process and product is exceptional.” Jason Matuszewski, Chief Executive Officer September 26, 2023 BioStem Technologies (OTC: BSEM) has received Investigational Review Board (IRB) approval for a clinical study that will investigate the utilization and effects of its Vendaje Ⓡ wound care product in diabetic foot ulcers. “We have already
-
BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje® in Diabetic Foot Ulcers
POMPANO BEACH, FLORIDA, September 26, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today the approval of an Investigational Review Board (IRB) sanctioned clinical study. This study aims to investigate the utilization and effects of